FDA Issues Pepaxto Warning to Multiple Myeloma Patients After Increased Mortality Rate in Trial Participants; What You Need to Know July 29, 2021By Chris Spargo
Mainstay of Treatment for Myeloma, Dexamethasone, Shows Very Significant Survival Benefit for COVID-19 Patients June 16, 2020By Georgina Berbari